Review History


All reviews of published articles are made public. This includes manuscript files, peer review comments, author rebuttals and revised materials. Note: This was optional for articles submitted before 13 February 2023.

Peer reviewers are encouraged (but not required) to provide their names to the authors when submitting their peer review. If they agree to provide their name, then their personal profile page will reflect a public acknowledgment that they performed a review (even if the article is rejected). If the article is accepted, then reviewers who provided their name will be associated with the article itself.

View examples of open peer review.

Summary

  • The initial submission of this article was received on October 10th, 2023 and was peer-reviewed by 2 reviewers and the Academic Editor.
  • The Academic Editor made their initial decision on January 3rd, 2024.
  • The first revision was submitted on April 18th, 2024 and was reviewed by 1 reviewer and the Academic Editor.
  • The article was Accepted by the Academic Editor on April 28th, 2024.

Version 0.2 (accepted)

· Apr 28, 2024 · Academic Editor

Accept

All issues pointed by the reviewers were addressed and revised manuscript is acceptable now.

[# PeerJ Staff Note - this decision was reviewed and approved by Paula Soares, a PeerJ Section Editor covering this Section #]

Reviewer 2 ·

Basic reporting

The issues have been improved.

Experimental design

The issues have been improved.

Validity of the findings

The issues have been improved.

Version 0.1 (original submission)

· Jan 3, 2024 · Academic Editor

Minor Revisions

Please address the concerns of both reviewers and amend the manuscript accordingly.

**PeerJ Staff Note:** Please ensure that all review, editorial, and staff comments are addressed in a response letter and that any edits or clarifications mentioned in the letter are also inserted into the revised manuscript where appropriate.

·

Basic reporting

The writing is clear and flows nicely throughout the paper. However, the discussion section needs to be reduced as it is a bit lengthy for the reader.

Experimental design

The experimental design is well thought out and fairly detailed with respect to the hypothesis the authors were trying to study. Kindly find detailed review with the attached annotated PDF.

Validity of the findings

Cuproptosis is not well studied in breast cancer and BRCA-positive breast cancer patients. This paper looks into understanding the relationship between cuproptosis in BRCA-breast cancer patients. The authors have done a detailed study regarding this and will add value to the breast cancer research.

Reviewer 2 ·

Basic reporting

1. Please provide x-axis title or y-axis title for Figures 1 C and D, Figures 3, 4, 6, 7, 8 and 9
2. What are TMB and NA in Figure 1C? Authors should spell out them in some place of the manuscript.
3. In line 90, the authors should introduce the information of the data in detail. E.g. the meaning of M, N, T, stage. Not all the readers are familiar with this simplified writing.
4. In line 94, the typo "GES42568" should be "GSE42568"
5. "OS" in line 120 should be spelled out for the first occurrence
6. Please increase the resolution of Figures 3, 4, 6, 7, 8. Many texts in the figure cannot be seen clearly.

Experimental design

1. The author used RNA-seq data from TCGA and microarray data from GEO. To find differential genes, the author only applied the limma package to the microarray data. There are much more RNA-seq data from TCGA. RNA-seq data has been shown better for gene expression analysis. Why authors do not use DEseq/EdgeR to find differential genes from RNA-seq data?
2. The authors do not provide batch effect analysis for TCGA and GEO datasets. If there are batch effects among the samples, the data should be preprocessed to remove the batch effect. Please ensure the subtypes of the samples are not due to the batch effect.
3. Why use PC1 and PC2 of PCA result for Cox regression in lines 119-122? Only six genes are found in line 253. Reducing the gene dimension is not necessary. I suggest authors use those genes as variables for the regression. In this way, the coefficient of the gene can be directed to interpret how the expression of these genes affects the prognosis. The significant level (p-value) of each coefficient can also support the inclusion or exclusion of the genes. In addition, please check the form of Cusig score in lines 123-124 is line 257 is not consistent. Maybe, the Cusig score in lines 123-124 is wrong and the i represents the sample ID.

Validity of the findings

1. The author should carefully check the batch effect of the data to ensure the subtype is not due to the batch effect.
2. The author should keep the consistency of differential genes between the results of microarray and RNA-seq data. Otherwise, one of them should be discarded due to the quality or other reasons.

All text and materials provided via this peer-review history page are made available under a Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.